'An interesting aside is that the ELISA test diagnostic market is forecast to hit US$4 billion by 2030 (worth US $2.35 billion in 2022)' - big deal?!
Just love the way you ignore the fact the DNA testing is ramping up at warp speed and will make Colostat obsolete - maybe the vast majority of ELISA tests dont need to be superseeded by DNA. Colostat on the other hand will - this was always going to happen eventually. Even before they lied to the market and sold shares on information NOT disclosed to us.
Enjoy your dream, Powerball has better odds of coming off than that bet.
Future Announcements, page-4
Add RHY (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $28.58M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5969 | 13.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.5¢ | 21297 | 1 |
View Market Depth
| Last trade - 16.16pm 15/11/2024 (20 minute delay) ? |
| RHY (ASX) Chart |
Day chart unavailable